# Suprasorb® CNPendo Used for Negative Pressure Therapy in the Oesophagus and Rectum to Support Defect and Wound Healing

> **NCT05476263** · — · RECRUITING · sponsor: **Lohmann & Rauscher** · enrollment: 110 (estimated)

## Conditions studied

- Esophagus Injury
- Rectal Lesion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05476263
- **Lead sponsor:** Lohmann & Rauscher
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476263, "Suprasorb® CNPendo Used for Negative Pressure Therapy in the Oesophagus and Rectum to Support Defect and Wound Healing". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05476263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*